assessments

The Limited Promise of a Malaria Vaccine

May 12, 2017 | 09:00 GMT
After delivering promising results in Phase III trials, a new malaria vaccine, Mosquirix, will enter use in a pilot program in Ghana, Malawi and Kenya in 2018. But shortcomings in the countries' health care sectors could limit the vaccine's efficacy.
(TONY KARUMBA/AFP/Getty Images)

Field tests show the medication's efficacy in about half of those who took it, but the limits of Africa's health care infrastructure could blunt its effect....

Connected Content

Article Search

Copyright © Stratfor Enterprises, LLC. All rights reserved.

Stratfor Worldview

OUR COMMITMENT

To empower members to confidently understand and navigate a continuously changing and complex global environment.

GET THE MOBILE APPGoogle Play